You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 103 No. 7, July 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  EXPEDITED PUBLICATION
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (39)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prevention of Intraocular Pressure Elevation Following Neodymium-YAG Laser Posterior Capsulotomy

Claudia U. Richter, MD; George Arzeno, MD; Harry R. Pappas, MD; Claudia A. Arrigg, MD; Paul Wasson, MD; Roger F. Steinert, MD

Arch Ophthalmol. 1985;103(7):912-915.


Abstract

• Thirty-two eyes of 32 patients were treated with 0.5% timolol, 2% pilocarpine, or normal saline five and 30 minutes following neodymium-YAG laser posterior capsulotomy in a randomized, double-masked study. Mean maximum intraocular pressure (IOP) elevation was 8 2 mm Hg following treatment with normal saline, 5 3 mm Hg following treatment with 2% pilocarpine, and 1 ± 2 mm Hg following treatment with 0.5% timolol. Fewer patients treated with 0.5% timolol developed an IOP elevation of 5 mm Hg or more than control patients. One aphakic patient treated with 0.5% timolol developed a maximum IOP greater than or equal to 40 mm Hg. We found that treatment with 0.5% timolol after neodymium-YAG laser posterior capsulotomy provides partial protection from IOP elevation.



Author Affiliations

From the Glaucoma Consultation Service, Massachusetts Eye and Ear Infirmary, and the Department of Ophthalmology, Harvard Medical School, Boston.


Footnotes

Accepted for publication May 16, 1985.

Reprint requests to 50 Staniford St, Boston, MA 02114 (Dr Richter).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Topical 2.0% Dorzolamide vs Oral Acetazolamide for Prevention of Intraocular Pressure Rise After Neodymium:YAG Laser Posterior Capsulotomy
Ladas et al.
Arch Ophthalmol 1997;115:1241-1244.
ABSTRACT  

10 Years: Over 10 000 Manuscripts
Goldberg
Arch Ophthalmol 1994;112:749-751.
ABSTRACT  

Late-Onset Elevation in Intraocular Pressure After Neodymium-YAG Laser Posterior Capsulotomy
Fourman and Apisson
Arch Ophthalmol 1991;109:511-513.
ABSTRACT  

Prevention of the Rise in Intraocular Pressure Following Neodymium-YAG Posterior Capsulotomy Using Topical 1% Apraclonidine
Pollack et al.
Arch Ophthalmol 1988;106:754-757.
ABSTRACT  

Intraocular Pressure Changes After Neodymium-YAG Laser Capsulotomy in Eyes Pretreated With Timolol: A Review of 373 Eyes
Migliori et al.
Arch Ophthalmol 1987;105:473-475.
ABSTRACT  

Q-Switched Neodymium-YAG Laser Iridotomy: A Field Trial With a Portable Laser System
Robin et al.
Arch Ophthalmol 1986;104:526-530.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.